inferior longitudinal fasciculus, cingulum bundle, and the anterior thalamic radiation. Shorter whole brain FBL sum metrics were associated with poorer neuropsychological performance, but were not associated with markers of disease burden. Taken together these findings suggest HIV affects white matter architecture primarily through reductions in white matter fiber numbers and, to a lesser degree, the shortening of fibers along a bundle path.
Introduction
impairment (Ances and Hammoud 2014) . Clinical studies reveal that the deleterious impact of HIV on brain structure and function is independent of viral clade (Buch et al. 2016) , including clade C (HIV-C) which is dominant in South Africa ((de Almeida et al. 2013) ; (Paul et al. 2014) ; Joska et al. 2010 Joska et al. , 2011 Joska et al. , 2012 ).
Neuroimaging outcomes in HIV-C correspond with the extant literature in HIV clade B (HIV-B), indicating smaller brain volumes Ortega et al. 2013) in treatment naïve HIV+ individuals compared to uninfected controls. Smaller volumes in gray and white matter, and the thalamus correlated with worse performance on brief measures of cognitive functioning such as the international HIV dementia screen and a four item neuropsychological battery (e.g. NPZ-4) Ortega et al. 2013) . Additionally, these smaller brain volumes correspond to measures of disease burden including lower CD4 cell counts and greater HIV viral load Ortega et al. 2013 ). In general, HIV studies of white matter using diffusion tensor imaging (DTI) show lower fractional anisotropy and increased diffusion in HIV+ individuals compared to controls (for review see Masters and Ances 2014; Thompson and Jahanshad 2015) . These changes may reflect demyelination and axonal degradation (Alexander et al. 2011) , are evident in early infection (Ragin et al. 2015) , in cART treated populations (Wright et al. 2012) , and may be intensified with age (Seider et al. 2016) . White matter microstructure has also been examined in pediatric and adult HIV+ individuals in South Africa, with abnormal DTI scalar metrics evident in HIV+ individuals independent of the genetic polymorphism in the viral Tat protein common in clade C disease (Paul et al. 2017) . Furthermore, studies have reported HIV-associated abnormal white matter microstructure in individuals with the APOE4 genotype (Hoare et al. 2013) , poor prospective memory , apathy (Hoare et al. 2010) , and children receiving antiretroviral therapy (ART; (Hoare et al. 2015) . Most recent studies in South Africa have found disruptions of structural brain networks in HIV+ individuals compared to healthy participants (Baker et al. 2017) .
One limitation of structural imaging and traditional approaches to DTI metrics is the lack of detail about the organization and microstructure of white matter tracts due to data averaging at the voxel or regional level. Additionally, single tensor models only capture the directionality of tracts along the primary eigenvector, although it is possible to use multi-tensor models. Quantitative tractography diffusion magnetic resonance imaging (qtdMRI) is an alternative diffusion processing technique with high sensitivity to changes in the microstructure of white matter fibers. Fiber bundle lengths (FBLs) are computed using scalar DTI metrics, such as FA, in concert with tractography methods to delineate bundles of nerve fibers. A number of metrics are available, such as average FBL weighted by scalar DTI metrics, or a summation of FBL in the whole brain or in a given white matter tract. The metrics provide information about the underlying microstructure of white matter in better detail than previous methods. Additional information about the length, volume, and organization of fibers within a tract of interest (TOI) can be obtained using qdtMRI (Correia et al. 2008) ). Previous investigations have demonstrated the clinical relevance of these metrics across several conditions (Baker et al. 2014) ; (Bolzenius et al. 2013) ; (Correia et al. 2008 ), but limited work has been conducted in HIV. Tate et al. utilized an early version of qtdMRI based on single fiber modeling to examine white matter integrity in 23 treatment-naive individuals with HIV-B compared to 20 HIV− controls. Results of the preliminary study revealed reduced tractography FA among HIV+ individuals at a global level, and a significant correlation between the imaging metric and worse cognitive performance. To date, no studies have examined white matter integrity in HIV-C using qtdMRI, and prior work has not utilized multi-fiber modeling which reduces limitations of single-tensor models such as partial volume effects or crossing fiber effects of prior tractography methods .
The purpose of this study was to examine differences in qtdMRI FBL in both whole brain and six TOI between HIV− and HIV+ individuals with HIV-C. The TOIs were selected to allow comparison to prior DTI studies in HIV Tate et al. 2010 ) and other FBL studies (Baker et al. 2016; Behrman-Lay et al. 2015; Bolzenius et al. 2015) . We selected average FBL and summed FBL metrics in both whole brain and selected tracts. The metrics were selected as they reflect complementary information about the underlying architecture of the white matter fibers that cannot be determined with standard DTI metrics such as FA and MD. Additionally, we chose long-range fiber bundles that connect the frontal lobe to the temportal, parietal, and occipital lobes. Average FBL reflects the average length of all the fibers within a given tract, or throughout the whole brain whereas summed FBL reflects the summation of all FBL within a tract or throughout the brain. In group comparisons, if average FBL is reduced in one group compared to the other this suggests an overall shortening of fibers. If summed FBL is reduced then it may reflect an overall loss of fibers, a change in the underlying architecture of the fiber, or reduction in fiber density. If they are both reduced, then this suggests both a loss of fibers as well as a shortening of fibers. We anticipated that HIV+ individuals would have shorter average FBL and summed FBL compared to HIV− individuals. We further examined the relationships between FBL metrics, markers of HIV disease burden (i.e., duration of infection, viral load, current CD4 cell count), and neuropsychological performance. We expected that FBL metrics would correlate with clinical laboratory variables and cognitive performance.
Methods

Participants
A total of 135 HIV+ individuals and 21 HIV− individuals completed neuroimaging at the University of Cape Town (UCT) in South Africa. All individuals consented to the protocol as approved by the ethics committee at UCT. In order to be included in the study, individuals were required to be between the ages of 18-45, speak Xhosa as their primary language, and have completed a minimum of five years of formal education. Additional inclusion criteria for the HIV+ group included: (1) Documented HIV serostatus by Elisa and confirmed by Western Blot; and (2) Naïve to (ART) or be within the first 30 days of ART initiation. Criteria for exclusion from the study for all participants were as follows:
(1) Any current or past major DSM-IV Axis I psychiatric condition that could significantly affect cognitive status (e.g., schizophrenia or bipolar disorder); (2) Confounding neurological disorders including multiple sclerosis and other CNS conditions; (3) Head injury with loss of consciousness greater than 30 min; (4) Clinical evidence of opportunistic CNS infections (e.g., toxoplasmosis, progressive multifocal leukoencephalopathy, neoplasms); (5) Current substance use or alcohol use disorder as determined by a structured interview; and (6) Visual evidence of brain injury (e.g. stroke) on neuroimaging.
Recruitment of HIV+ participants occurred at community ART clinics in Cape Town, South Africa. Interested participants consented to participate and then completed a detailed medical and demographic survey. Study participation was voluntary and individuals were free to withdraw from the study at any point. Participants were compensated for assessments and transportation was provided for each study visit. HIV− participants were recruited from regional Voluntary Counseling and Testing Clinics in Cape Town, South Africa and were required to have laboratory-confirmed seronegative status. Recruitment from these clinics was intended to minimize differences in key demographic variables between the two groups (e.g., language, education, socioeconomic status). The study was approved by the Human Ethics Committee of the University of Cape Town, South Africa and the University of Missouri-St. Louis Institutional Review Board.
HIV viral load, CD4 + cell counts, and duration of infection
Blood samples were collected within 1 week of the MRI acquisition. RNA was isolated from patient samples using the Abbott RealTime HIV-1 amplification reagent kit, according to the manufacturer's instructions. Viral load was calculated using the Abbott m2000sp and the Abbott m2000rt analysers (Abbott laboratories, Abbott Park, Illinois, USA). CD4 + cell count was analyzed from blood samples and completed on the FACSCalibur flow cytometer in conjunction with the MultiSET V1.1.2 software (BD Biosciences, San Jose, CA, USA). Date of HIV diagnosis was available from clinic records for the majority (n = 111) of HIV+ individuals.
PCR amplification and sequencing of the tat exon 1 region
The tat exon 1 region was amplified (HXB2 position 5831-6045) by polymerase chain reaction (PCR) using the Promega GoTaq Flexi Kit (Promega, Madison, WI) according to manufacturer's instructions. Details have been described previously (Paul et al. 2014) . In brief, The PCR products were purified, sequenced and analyzed. Nucleotide sequences were used to translate info into amino acid sequences. HIV subtypes were determined to confirm HIV-C clade status for study inclusion.
Neuroimaging acquisition
Imaging acquisition took place using a head-only Magnetom Allegra 3 T MRI scanning system (Siemens Medical Solutions, Erlangen, Germany) with a 4-channel phased-array head coil. A head stabilizer was used to minimize movement. Head placement was confirmed by a preliminary scout scan composed of three orthogonal planes. A T1-weighted magnetization-prepared rapid acquisition gradient echo (MP-RAGE) sequence was acquired using a T1-weighted three dimensional magnetization-prepared rapid acquisition gradient echo (MPRAGE) sequence (Time of repetition (TR)/inversion time (TI)/echo time (TE) = 2400/1000/2.38 milliseconds, flip angle = 8°, and voxel size = 1 × 1 × 1 mm3, as described in our initial study . Additional MRI sequences were obtained, including T2-weighted scans that were used primarily for the detection of white matter disease or other injury, but were not used in the processing of DWI images.
Axial diffusion-weighted images were acquired using a customized in-house single-shot multi-slice echo-planar pulse sequence. The tensor was encoded using 30 non-collinear diffusion-encoded directions that were repeated to provide 60 diffusion weighted volumes. All directions were acquired with a gradient weight of b = 1000s/mm 2 . Six baseline acquisitions with a diffusion weighting of ~ 0 s/mm 2 were also obtained and interleaved with the diffusion weighted volumes. The following parameters were used: TE-103 ms, TR 10 s, matrix 128 × 128, FOV 218 × 218 mm 70 contiguous isotropic 1.7 mm 3 voxels, full Fourier transform. Prior to image analysis, images were visually inspected and individuals who had evidence of white matter disease or visible lesions on T1 or T2 scans were excluded from further study participation.
Image analysis
Diffusion-weighted images (DWIs) were preprocessed using FSL 5.0 (Jenkinson et al. 2012) . DWIs were corrected for motion and eddy-current induced artifacts through affine registration to the first baseline volume using FSL FLIRT (Jenkinson and Smith 2001) with the mutual information criteria. The orientations of the gradient encoding directions were corrected by the rotation induced by these registrations (Leemans and Jones 2009) , and brain tissue was extracted using FSL brain extractions tool (BET) (Smith 2002 ) with a fraction threshold of 0.45. Diffusion tensor images were estimated for each subject using FSL DTIFIT.
Following this, a study-specific white matter atlas was created using DTI-TK (Zhang et al. 2007 ). The template diffusion tensor image was computed by iteratively deforming and averaging the population imaging data using the tensor-based deformable registration algorithm in DTI-TK (Zhang et al. 2006 ) with finite strain tensor reorientation and the deviatoric tensor similarity metric. This template was used to define inclusion and exclusion ROI masks for the anterior thalamic radiation (ATR), cingulum bundle (CING), the inferior frontal occipital fasciculus (IFOF), inferior longitudinal fasciculus (ILF), superior longitudinal fasciculus (SLF), and the uncinate fasciculus (UNC) (Mori and van Zijl 2002) . Whole brain tractography was performed in the template image, and subsets of curves were interactively selected to represent each TOI. For each bundle, two inclusion TOI masks and one exclusion TOI mask were drawn in template space using ITK-SNAP ). The exclusion mask was used to remove erroneous stray fibers that can occur due to limitations such as noise and voxel size . These masks were placed at opposite ends of each template tractography bundle, and drawn in reference to standard white matter atlases ((Catani and Thiebaut de Schotten 2012); (Oishi et al. 2009 
)).
Subject-specific fiber bundle metrics were computed as follows. First, the TOI inclusion and exclusion masks were deformed to subject native space using the DTI-TK registration. Whole brain tractography was then performed in subject native space and a subset of curves in the TOI was selected using the two inclusion and exclusion masks. Diffusion modeling for tractography used FSL XFIBRES to obtain ball-andsticks diffusion models in each voxel (Behrens et al. 2007 ). Model fitting was performed with two stick compartments to improve tractography in areas with complex anatomy, such as crossing fibers. Tractography was performed using an extension of the standard streamline approach to use multiple fibers per voxels with the following parameters: four seeds per voxel, an angle threshold of 50°, a minimum length of 10 mm, and a minimum volume fraction of 0.1. During tracking, a kernel regression estimation framework was used for smooth interpolation of the multi-fiber ball-andsticks models with a Gaussian kernel with a spatial bandwidth of 1.5 mm and voxel neighborhood of 7 × 7 × 7. Finally, the number of paths in each fiber bundle were calculated, then the average and sum FBL were computed from the distribution of streamline lengths in each bundle and retained for statistical analysis. Whole brain FBL-sum was calculated by summing the lengths of fiber bundles. Whole brain average FBL (FBL-avg) was calculated by averaging the lengths of fiber bundles. The FBL-avg of each TOI was calculated by computing the average length of all the fibers in the TOI. The FBL-sum of each TOI was calculated by summing the lengths of all the fibers in the TOI. Tracts of interest include: ATR, CING, IFOF, ILF, SLF, and UNC and were selected based on DTI findings in HIV as well as qtdMRI findings in other populations (Baker et al. 2014; BehrmanLay et al. 2015; Bolzenius et al. 2013; Salminen et al. 2013) . Intracranial volume was computed from the T 1 -weighted MRI using Freesurfer version 5.1.0 (Fischl 2012) .
Neuropsychological measures and depression screening
Neuropsychological methods are described in detail in Paul et al. (Paul et al. 2014) . Briefly, a trained research technician fluent in Xhosa administered tests in the following domains: Learning/Memory, Executive Function, and Psychomotor speed (Table 1) . HIV+ participants were screened for (Sheehan et al. 1998) or total score on the Center for Epidemiologic Studies depression screen (CESD; (Radloff 1991) . Individuals who screened positively for clinical depression were not included in the study.
Statistical analysis
Analyses were conducted with SPSS 23 (IBM; New York, NY). Primary analyses utilized Chi square tests and independent t-tests to examine demographic differences between groups on age, sex, and education (see Table 2 ). Additionally, we employed correlations between all of the FBL metrics, age, education, sex, and intracranial volume to determine the need for covariates in subsequent analyses. All variables were checked prior to analyses for normality of distributions. Holm's sequential Bonferroni was used to correct for multiple comparisons. Whole brain FBL-avg and FBL-sum between HIV− and HIV+ were separately examined using univariate analyses (SPSS General Linear Model Univariate procedure). In each model, HIV status was the primary independent variable with age, sex, and intracranial volume entered as covariates and whole brain FBL-avg the dependent variable in the first analysis, and whole brain FBL-sum as the dependent variable in the second analysis. Separate multivariate linear models were used (SPSS General Linear Model Multivariate procedure) to test the effect of HIV status on the six TOIs. HIV status was the primary independent variable with age, gender, and intracranial volume included as covariates (ATR, CING, IFOF, ILF, SLF, and UNC). The FBLavg values for each TOI were dependent variables i the first analysis, with FBL-sum TOIs as dependent variables in the second analysis. Post-hoc univariate analyses, adjusted for covariates, were used to determine which TOIs differed significantly between the groups. As a supplementary analysis, the effect of HIV status (with age, sex, and ICV as covariates) on the number of FBL paths in each TOI was examined using a multivariate model with the six TOIs as dependent variables. Spearman's correlations were completed to determine the degree of correspondence between the FBL metrics, duration of infection, current CD4 count, and viral load. CD4 cell count and viral load were natural log and log transformed, respectively, prior to analyses. Additional partial correlations controlling for age and intracranial volume were completed to inform the relationships between whole brain FBL metrics and the neuropsychological measures.
Results
Analysis of the demographic characteristics between the HIV+ and HIV− groups indicated significant group differences for age, sex, and education. The HIV+ group was older, on average (m = 31.8 years old, range 22-46) and had less education (m = 10.3 years) than the HIV− group (m = 24.2 years old, range 20-35, and m = 11.1 years of education). The HIV+ group was 81% female and the HIV− group was 52% female. All (100%) of the HIV+ group had a detectable viral load and 16.5% (n = 27) had initiated ART, with 6 of those individuals having received ART for less than 14 days. Education did not significantly correlate with any FBL measures (all rs < 0.2, ps > 0.05) and therefore we did not include education as a covariate in any of the analyses. Age, sex and intracranial volume were significantly correlated with several of the FBL measures and were therefore included as covariates in all of the FBL analyses.
HIV+ vs HIV− whole brain and tract-based FBL measures
Whole brain FBL-avg was similar between the two groups (F (4,153) = 1.91, p = 0.17, n 2 = 0.012). In contrast, whole brain FBL-sum was significantly higher in the HIV− group (m = 9811.4) compared to the HIV+ group (m = 8028.3, F (4, 153) = 24.93, p < 0.001, n 2 = 0.14, see Table 3 ). The multivariate analysis for tract-based FBL-avg indicated a significant multivariate effect of HIV status (Wilks' Lambda = 0.876, F (6, 146) = 3.45, p = 0.003, n 2 = 0.12) with the HIV+ group exhibiting significantly shorter FBL-avg compared to the HIV− group. In post-hoc univariate comparisons, HIV+ individuals exhibited shorter FBL-avg in the ILF (p < 0.01) and ATR (p < 0.01) after multiple comparison corrections (Holm-Bonferroni; (Holm 1979 ). The multivariate model for tract-based FBL-sum revealed a significant multivariate effect of HIV on FBL-sum (Wilks' Lambda = 0.875, F (6, 146) = 3.462, p = 0.003, n 2 = 0.13, see Table 4 ). All six tracts for FBL-sum were significantly less in the HIV+ group compared to the HIV− group in each TOI (Table 4) . A visualization of the tracts in a representative HIV+ subject compared to the template is provided in Fig. 1 .
As a supplementary analysis, we examined the number of FB paths for the TOIs using the same multivariate model describe above with HIV status as the primary independent variable and age, gender, and intracranial volume as covariates. The HIV+ group had fewer FB paths in all of the TOI, with significant group differences noted in four of the six tracts (CING, IFOF, SLF, UNC) compared to the HIV− group (see supplementary table 1). In a follow-up analysis, the whole brain and TOI analyses were repeated with the 27 individuals who had initiated ART removed from the HIV+ group leaving 108 HIV+ participants in the analysis. The pattern of results remained the same, with the HIV+ group having shorter FBL-sum, and shorter TOI in 4 of the 6 tracts examined (see supplementary table 2 for details).
Correlations between FBL metrics, disease burden, inflammatory markers, and neuropsychological performance
Neither CD4 count, nor time since diagnosis, nor viral load correlated with any of the FBL metrics. Whole brain FBL 
Discussion
This study extends the current literature examining the effect of HIV on white matter microstructure by examining the whole brain and TOI abnormalities in HIV-C. Differences were evident in whole brain FBL-sum, but not whole brain FBL-avg. Tract-specific FBL differences were also examined between the HIV+ and HIV− groups in six tracts of interest.
Our results provide the first in vivo evidence of shorter FBLsum in the ILF, SLF, ATR, IFOF, CING and UNC in HIV+ individuals. Additionally, there was an effect of HIV on the FBL-avg metric in the TOI, with the IFOF, ILF, CING and ATR tracts significantly shorter in the HIV+ group. Whole brain FBL metrics were modestly associated with neuropsychological performance, with higher FBL-sum corresponding with better performance. None of the FBL metrics were associated with markers of disease burden such as CD4 cell count, viral load, or duration of infection. These results provide seminal evidence of reduced sum of FBL in HIV whole brain and TOI, with shorter average FBL in select TOI. FBL provides unique characterizations of white matter fibers that are meant to represent the biological lengths of fiber bundles. Shorter average FBL theoretically reflect a shorter average length of all the fibers within a bundle, or group of axons. Similarly, FBL-sum reflects the summed length of all the fibers within a bundle. Smaller FBL-sum may reflect a combination of both shortening of the fibers and/or fewer fibers within the bundle resulting from factors, such as inflammation and viral toxicity, that promote neuronal degradation (Scaravilli et al. 2007 ). The whole brain FBL metrics each provide unique information about the architecture of white matter fiber bundles in the brain. However, unlike biological bundle length, FBL is also likely to be sensitive to microstructural changes within bundles, to some extent, for example, when changes to the microstructure are sufficiently abnormal to change the course of tractography constructions. In the current analysis, mean differences in FBL were not observed in the whole brain measures; however, HIV+ individuals exhibited shorter FBL-avg in the ILF, and the ATR. FBL-sum was reduced in all six TOI, and our supplementary analysis of number of FBL confirmed that there were significantly fewer fiber bundles in the ATR, CING, IFOF, and UNC. Taken together, our findings suggest that HIV neuropathogenesis in HIV-C initially involves reductions in the number of white matter fibers to a greater extent than average tract length. It is also possible that the changes along a fiber bundle take place at earlier stages of disease, and ultimately result in the reduced number of fibers, resulting in smaller FBL-sum values. Future work can help to better understand these factors by examining the relation between FBL and microstructural properties such as fiber orientation dispersion and neurite density. Reductions in FBL-avg and FBL-sum likely result from immune activation evident in untreated HIV and downstream effects on anisotropic diffusion of water along fiber bundles or myelin (Beaulieu 2002) . Studies have associated abnormalities in DTI metrics within specific tracts to cognitive deficits in the domains of processing speed, working memory, and executive functions (Biesbroek et al. 2013 ) as well as affective states, including apathy (Zappala et al. 2012) . Deficits in these cognitive domains are commonly reported in HIV (Heaton et al. 2010) ; (Paul et al. 2005; Tate et al. 2003) . The results of this study show an association between shorter whole brain FBL sum and poorer performance on measures of learning, memory, visuoconstruction, verbal fluency and executive function. However, the strength of the relationships is limited, and the cross-sectional nature of this study does not inform long-term outcomes after sustained ART with viral suppression. Since the results of this study indicate that reduced FBL sum is associated with poorer neuropsychological performance there is an indication that this is due to fewer FBL, as opposed to shorter fiber bundle length due to the lack of correlation between FBL average and the neuropsychological measures. It is also possible that adequate connections have atrophied, or become "disconnected" resulting in poorer neuropsychological performance.
One longitudinal study of DTI in HIV reported significant changes in diffusion metrics indicating progressive white matter and cognitive decline in an ART stable HIV+ group after one year (Chang et al. 2008 ). Conversely, a recent longitudinal study of HIV+ individuals on stable highlyactive ART did not find changes to DTI scalar metrics after approximately 26 months, but cognitive function was not assessed (Correa et al. 2016) . Additional studies will be critical to better understand whether there is potential for recovery of FBL through therapeutic interventions, and how FBL changes affect cognition and daily living functions.
There are several limitations to our study that warrant discussion. This study involved a cross-sectional design and as such we cannot determine the progression of FBL changes over time. Longitudinal studies will be key to understanding how FBL can change across time, with ART or other conjunctive therapies to protect the brain. A number of individuals in this study had recently initiated ART therapy (within 30 days of their MRI), which may impact the degree of correspondence between markers of CD4 and viral load to FBL. A relatively small number of HIV− controls were available for the study; however, there was sufficient power to detect strong differences between groups using FBL as a measure of white matter integrity. Untreated HIV has been associated with the development of white matter disease, and our exclusion of individuals with overt white matter disease may not be fully representative of individuals with untreated HIV. As indicated in our supplementary analysis, it is possible that ART initiation in the small percentage of participants in the study influenced the relationship between cognitive performance and FBL-sum TOI metrics. However, duration of treatment was under 30 days and all of the participants had detectable viral loads. Therefore, it is unlikely that ART initiation in this subset significantly affected the outcomes.
Our results confirm abnormalities in FBL-sum in whole brain and TOI among HIV+ individuals ART in South Africa. These abnormalities indicate that long-range fiber bundles connecting the frontal lobe to each the temporal, parietal, and occipital lobes have shorter summed FBL, on average, than HIV− individuals. Additionally, the results suggest global measurements of FBL-sum may be more powerful to detect white matter abnormalities in HIV than FBL-avg. Shorter sum of FBL indicates either reduced FBL fiber volume, or fibers that have shortened along the anatomical tract. However, a significant whole brain difference in FBL-avg was not evident; therefore, it is likely that a reduction in the number of fibers are driving the FBL-sum metric lower in HIV, and not shortening of fibers along a path. Given that the study population was naïve to ART or had newly initiated ART future work will be critical to understanding how stable treatment with ART may affect FBL metrics and neuropsychological performance. This study provides a snapshot of white matter integrity, and future studies following individuals over time are necessary to understand the trajectory of brain health using qtdMRI and potential legacy effects of ART in HIV. Furthermore, there are a number of host and viral factors (e.g. resilience, inflammatory markers, and HIV co-receptor tropism) that may affect how FBL change in HIV that remain to be examined.
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